Cameroon vs Sri Lanka: Previously treated cases tested for RR-/MDR-TB
Cameroon
100.0%
in 2024
Sri Lanka
100.0%
in 2024
Cameroon rank
1st
Sri Lanka rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Cameroon
- Sri Lanka
How they compare
Cameroon currently reports 100.0% against 100.0% in Sri Lanka, a difference of 0.0%.
The two have swapped places 4 times across 14 shared years of data; in 2009 it was Sri Lanka ahead.
Cameroon ranks 1st and Sri Lanka ranks 1st of 180 countries.
Across the 3 decades both report, Cameroon averaged higher in 1 and Sri Lanka in 2.
Head to head by decade
| Decade | Cameroon | Sri Lanka | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 14.0% | 100.0% | 86.0% | Sri Lanka |
| 2010s | 52.8% | 84.0% | 31.2% | Sri Lanka |
| 2020s | 98.2% | 81.5% | 16.8% | Cameroon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Cameroon or Sri Lanka?
- Cameroon, at 100.0% against 100.0% in Sri Lanka as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Cameroon and Sri Lanka?
- 0.0%, with Cameroon ahead.
- How many years of comparable data are there for Cameroon and Sri Lanka?
- 14 years are reported by both, from 2009 to 2024.
- How do Cameroon and Sri Lanka rank globally for previously treated cases tested for rr-/mdr-tb?
- Cameroon ranks 1st and Sri Lanka ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.